Staar Surgical STAA Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Staar Surgical in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Staar Surgical's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Staar Surgical's cash & equivalents?
- Staar Surgical (STAA) reported cash & equivalents of $131.86M in Q1 2026.
- How has Staar Surgical's cash & equivalents changed year-over-year?
- Staar Surgical's cash & equivalents decreased by 23.8% year-over-year, from $173.11M to $131.86M.
- What is the long-term trend for Staar Surgical's cash & equivalents?
- Over 5 years (2020 to 2025), Staar Surgical's cash & equivalents has grown at a 0.1% compound annual growth rate (CAGR), from $152.45M to $153.15M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.